{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T09:59:33Z","timestamp":1789984773398,"version":"4.0.1"},"reference-count":160,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":2094,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","fertstert.org","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.fertnstert.2016.08.031","type":"journal-article","created":{"date-parts":[[2016,8,24]],"date-time":"2016-08-24T12:20:56Z","timestamp":1472041256000},"page":"948-958","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":172,"title":["Polycystic ovary syndrome and environmental toxins"],"prefix":"10.1016","volume":"106","author":[{"given":"Aleksandra Zofia","family":"Rutkowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evanthia","family":"Diamanti-Kandarakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2016.08.031_bib1","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1017\/S1462399408000598","article-title":"Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications","volume":"10","author":"Diamanti-Kandarakis","year":"2008","journal-title":"Exp Rev Mol Med"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib2","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1210\/jcem.84.11.6148","article-title":"A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile","volume":"84","author":"Diamanti-Kandarakis","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib3","first-page":"2434","article-title":"A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain","volume":"85","author":"Asuncion","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib4","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib5","first-page":"752","article-title":"Polycystic ovary syndrome\u2014an update","volume":"41","author":"Boyle","year":"2012","journal-title":"Aust Fam Physician"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib6","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1210\/edrv.20.4.0374","article-title":"The insulin-related ovarian regulatory system in health and disease","volume":"20","author":"Poretsky","year":"1999","journal-title":"Endocr Rev"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpobgyn.2016.05.003","article-title":"Androgen excess: investigations and management","author":"Lizneva","year":"2016","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib8","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s12020-014-0200-7","article-title":"Prevalence and impact of hyperandrogenemia in 1,218 women with polycystic ovary syndrome","volume":"47","author":"Livadas","year":"2014","journal-title":"Endocrine"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib9","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(07)61345-2","article-title":"Polycystic ovary syndrome","volume":"370","author":"Norman","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1385\/ENDO:30:1:13","article-title":"Insulin resistance in PCOS","volume":"30","author":"Diamanti-Kandarakis","year":"2006","journal-title":"Endocrine"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib11","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1210\/er.2011-1034","article-title":"Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications","volume":"33","author":"Diamanti-Kandarakis","year":"2012","journal-title":"Endocrine Rev"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib12","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.mce.2009.09.026","article-title":"Ovarian function and obesity\u2014interrelationship, impact on women's reproductive lifespan and treatment options","volume":"316","author":"Rachon","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib13","doi-asserted-by":"crossref","first-page":"P1","DOI":"10.1530\/EJE-14-0253","article-title":"The polycystic ovary syndrome: a position statement from the European Society of Endocrinology","volume":"171","author":"Conway","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib14","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/sj.ijo.0801994","article-title":"Obesity and the polycystic ovary syndrome","volume":"26","author":"Gambineri","year":"2002","journal-title":"Int J Obesity Rel Metab Disord"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib15","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0015-0282(03)00265-6","article-title":"Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome","volume":"79","author":"Yildirim","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib16","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.tem.2003.08.002","article-title":"Polycystic ovary syndrome: syndrome XX?","volume":"14","author":"Sam","year":"2003","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib17","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.tem.2007.07.004","article-title":"Pathophysiology and types of dyslipidemia in PCOS","volume":"18","author":"Diamanti-Kandarakis","year":"2007","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib18","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1210\/jc.2007-1756","article-title":"A more atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome: a case-control study","volume":"93","author":"Valkenburg","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib19","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/cen.12447","article-title":"Visceral adiposity index (VAI) is related to the severity of anovulation and other clinical features in women with polycystic ovary syndrome","volume":"81","author":"Androulakis","year":"2014","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib20","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S0015-0282(99)00401-X","article-title":"Alterations in low-density lipoprotein and high-density lipoprotein subclasses among Hispanic women with polycystic ovary syndrome: influence of insulin and genetic factors","volume":"72","author":"Legro","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib21","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00774-010-0211-2","article-title":"Serum concentrations of carboxylated osteocalcin are increased and associated with several components of the polycystic ovarian syndrome","volume":"29","author":"Diamanti-Kandarakis","year":"2011","journal-title":"J Bone Min Metab"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib22","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1210\/jc.2009-2724","article-title":"Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society","volume":"95","author":"Wild","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib23","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1210\/jc.2005-2430","article-title":"Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome","volume":"91","author":"Lo","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib24","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/humrep\/deq310","article-title":"Phenotype and metabolic profile of South Asian women with polycystic ovary syndrome (PCOS): results of a large database from a specialist Endocrine Clinic","volume":"26","author":"Wijeyaratne","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib25","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s11154-016-9338-3","article-title":"Introduction to endocrine disrupting chemicals\u2014is it time to act?","volume":"16","author":"Koch","year":"2015","journal-title":"Rev Endocrine Metab Disord"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib26","doi-asserted-by":"crossref","first-page":"A104","DOI":"10.1289\/ehp.1205448","article-title":"The impact of endocrine disruption: a consensus statement on the state of the science","volume":"121","author":"Bergman","year":"2013","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib27","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/toxsci\/kfu231","article-title":"Human sex hormone\u2013binding globulin binding affinities of 125 structurally diverse chemicals and comparison with their binding to androgen receptor, estrogen receptor, and alpha-fetoprotein","volume":"143","author":"Hong","year":"2015","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib28","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/1062936X.2014.909197","article-title":"Modelling the binding affinity of steroids to zebrafish sex hormone-binding globulin","volume":"25","author":"Saxena","year":"2014","journal-title":"SAR QSAR Environ Res"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib29","doi-asserted-by":"crossref","first-page":"e0151444","DOI":"10.1371\/journal.pone.0151444","article-title":"Endocrine disruption: computational perspectives on human sex hormone\u2013binding globulin and phthalate plasticizers","volume":"11","author":"Sheikh","year":"2016","journal-title":"PloS One"},{"issue":"Suppl 4","key":"10.1016\/j.fertnstert.2016.08.031_bib30","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1289\/ehp.96104s4715","article-title":"Research needs for the risk assessment of health and environmental effects of endocrine disruptors: a report of the U.S. EPA-sponsored workshop","volume":"104","author":"Kavlock","year":"1996","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib31","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1210\/er.2009-0002","article-title":"Endocrine-disrupting chemicals: an Endocrine Society scientific statement","volume":"30","author":"Diamanti-Kandarakis","year":"2009","journal-title":"Endocrine Rev"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib32","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1210\/endo.139.10.6216","article-title":"Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta","volume":"139","author":"Kuiper","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib33","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.yrtph.2005.07.001","article-title":"Weighing the results of differing \u2018low dose\u2019 studies of the mouse prostate by Nagel, Cagen, and Ashby: quantification of experimental power and statistical results","volume":"43","author":"Owens","year":"2005","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib34","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1210\/er.2011-1050","article-title":"Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses","volume":"33","author":"Vandenberg","year":"2012","journal-title":"Endocrine Rev"},{"issue":"Pt 2","key":"10.1016\/j.fertnstert.2016.08.031_bib35","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1042\/bj3400405","article-title":"Glucuronidation of the environmental oestrogen bisphenol A by an isoform of UDP-glucuronosyltransferase, UGT2B1, in the rat liver","volume":"340","author":"Yokota","year":"1999","journal-title":"Biochem J"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib36","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.bbrc.2003.10.135","article-title":"Gender differences in the levels of bisphenol A metabolites in urine","volume":"312","author":"Kim","year":"2003","journal-title":"Biochem Biophys Res Comm"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib37","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1210\/jc.2015-2571","article-title":"Pivotal role for the visceral fat compartment in the release of persistent organic pollutants during weight loss","volume":"100","author":"Dirinck","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib38","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1093\/humrep\/deg254","article-title":"High plasma concentrations of di-(2-ethylhexyl)-phthalate in women with endometriosis","volume":"18","author":"Cobellis","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib39","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1093\/humrep\/17.11.2839","article-title":"Determination of bisphenol A concentrations in human biological fluids reveals significant early prenatal exposure","volume":"17","author":"Ikezuki","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib40","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.reprotox.2007.07.010","article-title":"Human exposure to bisphenol A (BPA)","volume":"24","author":"Vandenberg","year":"2007","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2016.05.009","article-title":"Adverse effects of weight loss: Are persistent organic pollutants a potential culprit?","author":"Cheikh Rouhou","year":"2016","journal-title":"Diabet Metab"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib42","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1289\/ehp.1001993","article-title":"Bisphenol A exposure during pregnancy disrupts glucose homeostasis in mothers and adult male offspring","volume":"118","author":"Alonso-Magdalena","year":"2010","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib43","doi-asserted-by":"crossref","first-page":"B105","DOI":"10.1093\/geronj\/45.4.B105","article-title":"Nonenzymatic glycosylation, the Maillard reaction and the aging process","volume":"45","author":"Monnier","year":"1990","journal-title":"J Gerontol"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib44","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s001250051591","article-title":"Advanced glycation end-products: a review","volume":"44","author":"Singh","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib45","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2174\/1871527313666140806144831","article-title":"Receptor for AGEs (RAGE) as mediator of NF-kB pathway activation in neuroinflammation and oxidative stress","volume":"13","author":"Tobon-Velasco","year":"2014","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib46","first-page":"985","article-title":"RAGE in inflammation: a new therapeutic target?","volume":"7","author":"Bierhaus","year":"2006","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib47","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1161\/CIRCULATIONAHA.106.621854","article-title":"Advanced glycation end products: sparking the development of diabetic vascular injury","volume":"114","author":"Goldin","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib48","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2337\/diabetes.52.3.621","article-title":"Acute hyperglycemia causes intracellular formation of CML and activation of ras, p42\/44 MAPK, and nuclear factor kappaB in PBMCs","volume":"52","author":"Schiekofer","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib49","doi-asserted-by":"crossref","first-page":"14987","DOI":"10.1016\/S0021-9258(18)42137-0","article-title":"Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface","volume":"267","author":"Schmidt","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib50","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1254\/jphs.CPJ04005X","article-title":"Roles of the receptor for advanced glycation endproducts in diabetes-induced vascular injury","volume":"97","author":"Yonekura","year":"2005","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib51","first-page":"415","article-title":"Current perspectives on the health risks associated with the consumption of advanced glycation end products: recommendations for dietary management","volume":"8","author":"Palimeri","year":"2015","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib52","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s11154-016-9326-7","article-title":"Polycystic ovary syndrome (PCOS) and endocrine disrupting chemicals (EDCs)","volume":"16","author":"Palioura","year":"2015","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib53","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.2174\/1381612822666160216151852","article-title":"Oxidative stress in polycystic ovary syndrome","volume":"22","author":"Papalou","year":"2016","journal-title":"Curr Pharmaceut Des"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib54","doi-asserted-by":"crossref","first-page":"e0138438","DOI":"10.1371\/journal.pone.0138438","article-title":"Androgen and progesterone receptors are targets for bisphenol\u00a0A (BPA), 4-Methyl-2,4-bis-(P-Hydroxyphenyl)Pent-1-Ene\u2014a potent metabolite of BPA, and 4-Tert-Octylphenol: a computational insight","volume":"10","author":"Rehan","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib55","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/jb\/mvp049","article-title":"Placenta expressing the greatest quantity of bisphenol A receptor ERR{gamma} among the human reproductive tissues: predominant expression of type-1 ERRgamma isoform","volume":"146","author":"Takeda","year":"2009","journal-title":"J Biochem"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib56","first-page":"403","article-title":"Nonenzymatic glycation of plasma proteins in smokers","volume":"50","author":"Venkatesan","year":"2006","journal-title":"Indian J Physiol Pharmacol"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib57","doi-asserted-by":"crossref","first-page":"6474","DOI":"10.1073\/pnas.94.12.6474","article-title":"Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy","volume":"94","author":"Koschinsky","year":"1997","journal-title":"Proc Nat Acad Sci U S A"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib58","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1196\/annals.1333.052","article-title":"Diet-derived advanced glycation end products are major contributors to the body\u2019s AGE pool and induce inflammation in healthy subjects","volume":"1043","author":"Uribarri","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib59","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0272-6386(03)00779-0","article-title":"Dietary glycotoxins correlate with circulating advanced glycation end product levels in renal failure patients","volume":"42","author":"Uribarri","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib60","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.jada.2004.05.214","article-title":"Advanced glycoxidation end products in commonly consumed foods","volume":"104","author":"Goldberg","year":"2004","journal-title":"J Am Diet Assoc"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib61","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1210\/en.2005-1159","article-title":"Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure","volume":"147","author":"Welshons","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib62","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3109\/09513590.2013.871517","article-title":"(BPA) and its potential role in the pathogenesis of the polycystic ovary syndrome (PCOS)","volume":"30","author":"Rutkowska","year":"2014","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib63","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1507\/endocrj.51.165","article-title":"Positive relationship between androgen and the endocrine disruptor, bisphenol A, in normal women and women with ovarian dysfunction","volume":"51","author":"Takeuchi","year":"2004","journal-title":"Endocr J"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib64","doi-asserted-by":"crossref","first-page":"E480","DOI":"10.1210\/jc.2010-1658","article-title":"Endocrine disruptors and polycystic ovary syndrome (PCOS): elevated serum levels of bisphenol A in women with PCOS","volume":"96","author":"Kandaraki","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib65","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1111\/apa.12885","article-title":"The endocrine disruptor bisphenol A may play a role in the aetiopathogenesis of polycystic ovary syndrome in adolescent girls","volume":"104","author":"Akin","year":"2015","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib66","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1365-2265.2012.04500.x","article-title":"Bisphenol A in polycystic ovary syndrome and its association with liver-spleen axis","volume":"78","author":"Tarantino","year":"2013","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib67","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1472-6823-14-86","article-title":"Exploring the potential association between brominated diphenyl ethers, polychlorinated biphenyls, organochlorine pesticides, perfluorinated compounds, phthalates, and bisphenol A in polycystic ovary syndrome: a case-control study","volume":"14","author":"Vagi","year":"2014","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib68","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1093\/humrep\/dev123","article-title":"Association of serum levels of typical organic pollutants with polycystic ovary syndrome (PCOS): a case-control study","volume":"30","author":"Yang","year":"2015","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib69","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1365-2265.2008.03247.x","article-title":"Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS)","volume":"69","author":"Diamanti-Kandarakis","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib70","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2265.2004.02170.x","article-title":"Increased levels of serum advanced glycation end-products in women with polycystic ovary syndrome","volume":"62","author":"Diamanti-Kandarakis","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib71","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00418-006-0265-3","article-title":"Immunohistochemical localization of advanced glycation end-products (AGEs) and their receptor (RAGE) in polycystic and normal ovaries","volume":"127","author":"Diamanti-Kandarakis","year":"2007","journal-title":"Histochem Cell Biol"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib72","doi-asserted-by":"crossref","first-page":"7502","DOI":"10.1038\/ncomms8502","article-title":"Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations","volume":"6","author":"Hayes","year":"2015","journal-title":"Nat Comm"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib73","doi-asserted-by":"crossref","first-page":"270","DOI":"10.2174\/138161212799040457","article-title":"Phenotypes and enviromental factors: their influence in PCOS","volume":"18","author":"Diamanti-Kandarakis","year":"2012","journal-title":"Curr Pharmaceut Des"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib74","doi-asserted-by":"crossref","first-page":"e27286","DOI":"10.1371\/journal.pone.0027286","article-title":"Epigenetic mechanism underlying the development of polycystic ovary syndrome (PCOS)-like phenotypes in prenatally androgenized rhesus monkeys","volume":"6","author":"Xu","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib75","doi-asserted-by":"crossref","first-page":"e36129","DOI":"10.1371\/journal.pone.0036129","article-title":"Environmentally induced epigenetic transgenerational inheritance of ovarian disease","volume":"7","author":"Nilsson","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib76","doi-asserted-by":"crossref","first-page":"e31901","DOI":"10.1371\/journal.pone.0031901","article-title":"Transgenerational actions of environmental compounds on reproductive disease and identification of epigenetic biomarkers of ancestral exposures","volume":"7","author":"Manikkam","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib77","doi-asserted-by":"crossref","first-page":"e66318","DOI":"10.1371\/journal.pone.0066318","article-title":"Environmentally induced transgenerational epigenetic reprogramming of primordial germ cells and the subsequent germ line","volume":"8","author":"Skinner","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib78","doi-asserted-by":"crossref","first-page":"e55387","DOI":"10.1371\/journal.pone.0055387","article-title":"Plastics derived endocrine disruptors (BPA, DEHP and DBP) induce epigenetic transgenerational inheritance of obesity, reproductive disease and sperm epimutations","volume":"8","author":"Manikkam","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib79","doi-asserted-by":"crossref","first-page":"e102091","DOI":"10.1371\/journal.pone.0102091","article-title":"Pesticide methoxychlor promotes the epigenetic transgenerational inheritance of adult-onset disease through the female germline","volume":"9","author":"Manikkam","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib80","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11154-007-9046-0","article-title":"Polycystic ovary syndrome and its developmental origins","volume":"8","author":"Dumesic","year":"2007","journal-title":"Rev Endocrine Metab Disord"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib81","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1055\/s-0034-1371087","article-title":"Intrauterine environment and polycystic ovary syndrome","volume":"32","author":"Dumesic","year":"2014","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib82","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000134831","article-title":"Fetal programming of adrenal androgen excess: lessons from a nonhuman primate model of polycystic ovary syndrome","volume":"13","author":"Abbott","year":"2008","journal-title":"Endocr Dev"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib83","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0303-7207(01)00632-3","article-title":"Intra-follicular activin availability is altered in prenatally-androgenized lambs","volume":"185","author":"West","year":"2001","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib84","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/humupd\/dmi013","article-title":"Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome?","volume":"11","author":"Abbott","year":"2005","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib85","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1095\/biolreprod.110.086686","article-title":"Developmental programming: impact of excess prenatal testosterone on intrauterine fetal endocrine milieu and growth in sheep","volume":"84","author":"Veiga-Lopez","year":"2011","journal-title":"Biol Reprod"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib86","article-title":"Prenatal exposure to endocrine disruptors: a developmental etiology for polycystic ovary syndrome","author":"Hewlett","year":"2016","journal-title":"Reprod Sci"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib87","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1289\/ehp.01109675","article-title":"Perinatal exposure to low doses of bisphenol A affects body weight, patterns of estrous cyclicity, and plasma LH levels","volume":"109","author":"Rubin","year":"2001","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib88","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1593\/neo.04217","article-title":"Developmental effects of prenatal exposure to bisphenol a on the uterus of rat offspring","volume":"6","author":"Schonfelder","year":"2004","journal-title":"Neoplasia"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib89","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/sj.neo.7900212","article-title":"In utero exposure to low doses of bisphenol A lead to long-term deleterious effects in the vagina","volume":"4","author":"Schonfelder","year":"2002","journal-title":"Neoplasia"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib90","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1289\/ehp.0901257","article-title":"Neonatal exposure to bisphenol A and reproductive and endocrine alterations resembling the polycystic ovarian syndrome in adult rats","volume":"118","author":"Fernandez","year":"2010","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib91","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1289\/ehp.0800267","article-title":"Neonatal exposure to bisphenol A alters reproductive parameters and gonadotropin releasing hormone signaling in female rats","volume":"117","author":"Fernandez","year":"2009","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib92","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/humrep\/der448","article-title":"Endocrine-disrupting chemicals in human follicular fluid impair in\u00a0vitro oocyte developmental competence","volume":"27","author":"Petro","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib93","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/j.theriogenology.2012.06.011","article-title":"Endocrine disruptors and female fertility: focus on (bovine) ovarian follicular physiology","volume":"78","author":"Petro","year":"2012","journal-title":"Theriogenology"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib94","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1095\/biolreprod.115.130336","article-title":"Effects of endocrine-disrupting chemicals on the ovary","volume":"93","author":"Patel","year":"2015","journal-title":"Biol Reprod"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib95","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.mce.2007.10.010","article-title":"Effect of bisphenol A on steroid hormone production in rat ovarian theca-interstitial and granulosa cells","volume":"283","author":"Zhou","year":"2008","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib96","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.tiv.2008.12.017","article-title":"Effects of selected endocrine disruptors on meiotic maturation, cumulus expansion, synthesis of hyaluronan and progesterone by porcine oocyte-cumulus complexes","volume":"23","author":"Mlynarcikova","year":"2009","journal-title":"Toxicol In\u00a0Vitro"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib97","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1101\/gr.135681.111","article-title":"Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of sites in a cell type-specific manner","volume":"22","author":"Gertz","year":"2012","journal-title":"Genome Res"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib98","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.reprotox.2011.06.118","article-title":"Neonatal exposure to bisphenol A or diethylstilbestrol alters the ovarian follicular dynamics in the lamb","volume":"32","author":"Rivera","year":"2011","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib99","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/toxsci\/kft271","article-title":"Coexposure to phytoestrogens and bisphenol a mimics estrogenic effects in an additive manner","volume":"138","author":"Katchy","year":"2014","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib100","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jsbmb.2006.09.017","article-title":"Binding and activation of the seven-transmembrane estrogen receptor GPR30 by environmental estrogens: a potential novel mechanism of endocrine disruption","volume":"102","author":"Thomas","year":"2006","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib101","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.bbrc.2008.06.050","article-title":"ERRgamma tethers strongly bisphenol A and 4-alpha-cumylphenol in an induced-fit manner","volume":"373","author":"Matsushima","year":"2008","journal-title":"Biochem Biophys Res Comm"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib102","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.reprotox.2007.07.006","article-title":"Long-term adverse effects of neonatal exposure to bisphenol A on the murine female reproductive tract","volume":"24","author":"Newbold","year":"2007","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib103","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.1525-142X.2003.03011.x","article-title":"Mammalian development in a changing environment: exposure to endocrine disruptors reveals the developmental plasticity of steroid-hormone target organs","volume":"5","author":"Markey","year":"2003","journal-title":"Evol Devel"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib104","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1530\/REP-07-0460","article-title":"Mono-(2-ethylhexyl) phthalate stimulates basal steroidogenesis by a cAMP-independent mechanism in mouse gonadal cells of both sexes","volume":"135","author":"Gunnarsson","year":"2008","journal-title":"Reproduction"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib105","doi-asserted-by":"crossref","first-page":"e10201","DOI":"10.1371\/journal.pone.0010201","article-title":"DEHP impairs zebrafish reproduction by affecting critical factors in oogenesis","volume":"5","author":"Carnevali","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib106","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1289\/ehp.5658","article-title":"Mechanisms of phthalate ester toxicity in the female reproductive system","volume":"111","author":"Lovekamp-Swan","year":"2003","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib107","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.3390\/nu7125524","article-title":"Advanced glycation end products: link between diet and ovulatory dysfunction in PCOS?","volume":"7","author":"Garg","year":"2015","journal-title":"Nutrients"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib108","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1042\/BST20140023","article-title":"Dicarbonyl stress and glyoxalases in ovarian function","volume":"42","author":"Tatone","year":"2014","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib109","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/humupd\/dmm048","article-title":"Cellular and molecular aspects of ovarian follicle ageing","volume":"14","author":"Tatone","year":"2008","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib110","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.toxlet.2010.09.015","article-title":"Ovotoxicity and PPAR-mediated aromatase downregulation in female Sprague-Dawley rats following combined oral exposure to benzo[a]pyrene and di-(2-ethylhexyl) phthalate","volume":"199","author":"Xu","year":"2010","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib111","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0039-128X(98)00114-7","article-title":"Xenoestrogen interaction with human sex hormone-binding globulin (hSHBG)","volume":"64","author":"Dechaud","year":"1999","journal-title":"Steroids"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib112","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s002040050518","article-title":"Suppression of male-specific cytochrome P450 isoforms by bisphenol A in rat liver","volume":"72","author":"Hanioka","year":"1998","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib113","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1507\/endocrj.K06-032","article-title":"Elevated serum bisphenol A levels under hyperandrogenic conditions may be caused by decreased UDP-glucuronosyltransferase activity","volume":"53","author":"Takeuchi","year":"2006","journal-title":"Endocr J"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib114","doi-asserted-by":"crossref","first-page":"13240","DOI":"10.3390\/ijerph121013240","article-title":"Associations between bisphenol A exposure and reproductive hormones among female workers","volume":"12","author":"Miao","year":"2015","journal-title":"Int J Environ Res Pub Health"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib115","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.tem.2014.12.003","article-title":"Metabolic risk in PCOS: phenotype and adiposity impact","volume":"26","author":"Moran","year":"2015","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib116","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMra041536","article-title":"Polycystic ovary syndrome","volume":"352","author":"Ehrmann","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib117","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/humrep\/16.6.1255","article-title":"Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome","volume":"16","author":"Kirchengast","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib118","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/j.1471-0528.2006.00990.x","article-title":"The impact of obesity on reproduction in women with polycystic ovary syndrome","volume":"113","author":"Pasquali","year":"2006","journal-title":"Br J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib119","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2265.1990.tb00857.x","article-title":"Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases","volume":"32","author":"Kiddy","year":"1990","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib120","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1152\/physrev.00015.2004","article-title":"Hormonal regulation of food intake","volume":"85","author":"Stanley","year":"2005","journal-title":"Physiol Rev"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib121","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1381612822666160714094404","article-title":"Do advanced glycation end products (AGEs) contribute to the comorbidities of polycystic ovary syndrome (PCOS)?","volume":"22","author":"Rutkowska","year":"2016","journal-title":"Curr Pharmaceut Design"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib122","doi-asserted-by":"crossref","first-page":"e36610","DOI":"10.1371\/journal.pone.0036610","article-title":"Methylglyoxal mediates adipocyte proliferation by increasing phosphorylation of Akt1","volume":"7","author":"Jia","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib123","doi-asserted-by":"crossref","first-page":"E1726","DOI":"10.1210\/jc.2012-1473","article-title":"Endogenous secretory RAGE in obese women: association with platelet activation and oxidative stress","volume":"97","author":"Vazzana","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib124","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijcard.2007.10.047","article-title":"Association between endogenous secretory RAGE, inflammatory markers and arterial stiffness","volume":"132","author":"Choi","year":"2009","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib125","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1161\/01.ATV.0000190660.32863.cd","article-title":"Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis","volume":"25","author":"Koyama","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib126","first-page":"167","article-title":"Role of advanced glycation end-products in obesity-related ovarian dysfunction","volume":"39","author":"Merhi","year":"2014","journal-title":"Minerva Endocrinol"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib127","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1210\/me.2009-0261","article-title":"Prenatal exposure to the environmental obesogen tributyltin predisposes multipotent stem cells to become adipocytes","volume":"24","author":"Kirchner","year":"2010","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib128","first-page":"a62","article-title":"Obesogens: an environmental link to obesity","volume":"120","author":"Holtcamp","year":"2012","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib129","doi-asserted-by":"crossref","first-page":"206","DOI":"10.14310\/horm.2002.1271","article-title":"Impact of environmental endocrine disrupting chemicals on the development of obesity","volume":"9","author":"Newbold","year":"2010","journal-title":"Hormones (Athens)"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib130","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1467-789X.2011.00871.x","article-title":"Endocrine-disrupting chemicals and obesity development in humans: a review","volume":"12","author":"Tang-Peronard","year":"2011","journal-title":"Obes Rev"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib131","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1289\/ehp.1409062","article-title":"Association of prenatal exposure to persistent organic pollutants with obesity and cardiometabolic traits in early childhood: the Rhea Mother-Child Cohort (Crete, Greece)","volume":"123","author":"Vafeiadi","year":"2015","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib132","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3945\/ajcn.113.066720","article-title":"Association between prenatal polychlorinated biphenyl exposure and obesity development at ages 5 and 7 y: a prospective cohort study of 656 children from the Faroe Islands","volume":"99","author":"Tang-Peronard","year":"2014","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib133","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1476-069X-11-21","article-title":"Serum concentrations of phthalate metabolites are related to abdominal fat distribution two years later in elderly women","volume":"11","author":"Lind","year":"2012","journal-title":"Environ Health"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib134","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.tiv.2012.09.018","article-title":"Assay of vtg, ERs and PPARs as endpoint for the rapid in\u00a0vitro screening of the harmful effect of Di-(2-ethylhexyl)-phthalate (DEHP) and phthalic acid (PA) in zebrafish primary hepatocyte cultures","volume":"27","author":"Maradonna","year":"2013","journal-title":"Toxicol In\u00a0Vitro"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib135","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1289\/ehp.11342","article-title":"Perinatal exposure to bisphenol a alters early adipogenesis in the rat","volume":"117","author":"Somm","year":"2009","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib136","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/toxsci\/kfi088","article-title":"Bisphenol A accelerates terminal differentiation of 3T3-L1 cells into adipocytes through the phosphatidylinositol 3-kinase pathway","volume":"84","author":"Masuno","year":"2005","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib137","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1254\/jphs.FM0070034","article-title":"Life style\u2013related diseases of the digestive system: endocrine disruptors stimulate lipid accumulation in target cells related to metabolic syndrome","volume":"105","author":"Wada","year":"2007","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib138","first-page":"30","article-title":"Metabolic syndrome: polycystic ovary syndrome","volume":"435","author":"Mortada","year":"2015","journal-title":"FP Essent"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib139","first-page":"142","article-title":"The polycystic ovary syndrome: an update on metabolic and hormonal mechanisms","volume":"8","author":"Dumitrescu","year":"2015","journal-title":"J Med Life"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib140","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1093\/humrep\/dep049","article-title":"Androgen circle of polycystic ovary syndrome","volume":"24","author":"Homburg","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib141","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0015-0282(16)60060-2","article-title":"The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism","volume":"50","author":"Barbieri","year":"1988","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib142","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2265.1993.tb02376.x","article-title":"The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries","volume":"39","author":"Robinson","year":"1993","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib143","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1210\/jcem-65-3-499","article-title":"Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and\/or hyperinsulinemia","volume":"65","author":"Dunaif","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib144","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2174\/156652412798376161","article-title":"The emerging role of endocrine disruptors in pathogenesis of insulin resistance: a concept implicating nonalcoholic fatty liver disease","volume":"12","author":"Polyzos","year":"2012","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib145","article-title":"Bisphenol A is associated with insulin resistance and modulates adiponectin and resistin gene expression in obese children","author":"Menale","year":"2016","journal-title":"Pediatr Obes"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib146","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1289\/ehp.11537","article-title":"Bisphenol A at environmentally relevant doses inhibits adiponectin release from human adipose tissue explants and adipocytes","volume":"116","author":"Hugo","year":"2008","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib147","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.mce.2009.02.022","article-title":"Effects of bisphenol A on adipokine release from human adipose tissue: Implications for the metabolic syndrome","volume":"304","author":"Ben-Jonathan","year":"2009","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib148","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1289\/ehp.8451","article-title":"The estrogenic effect of bisphenol A disrupts pancreatic beta-cell function in\u00a0vivo and induces insulin resistance","volume":"114","author":"Alonso-Magdalena","year":"2006","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib149","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1001\/jama.300.11.1303","article-title":"Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults","volume":"300","author":"Lang","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib150","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1289\/ehp.8002","article-title":"Low doses of bisphenol A and diethylstilbestrol impair Ca2+ signals in pancreatic alpha-cells through a nonclassical membrane estrogen receptor within intact islets of Langerhans","volume":"113","author":"Alonso-Magdalena","year":"2005","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib151","doi-asserted-by":"crossref","first-page":"47376","DOI":"10.1074\/jbc.M301088200","article-title":"Human glycated albumin affects glucose metabolism in L6 skeletal muscle cells by impairing insulin-induced insulin receptor substrate (IRS) signaling through a protein kinase C alpha-mediated mechanism","volume":"278","author":"Miele","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib152","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1177\/1535370215584937","article-title":"Advanced glycation end-products and insulin signaling in granulosa cells","volume":"241","author":"Diamanti-Kandarakis","year":"2016","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib153","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11010-007-9563-x","article-title":"Accumulation of endogenous methylglyoxal impaired insulin signaling in adipose tissue of fructose-fed rats","volume":"306","author":"Jia","year":"2007","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib154","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0898-6568(01)00152-8","article-title":"Tumor necrosis factor-alpha is induced through phorbol ester\u2014and glycated human albumin-dependent pathway in THP-1 cells","volume":"13","author":"Naitoh","year":"2001","journal-title":"Cell Signal"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib155","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.2337\/diabetes.51.7.2082","article-title":"Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db\/db mouse","volume":"51","author":"Hofmann","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib156","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.2337\/diabetes.54.8.2314","article-title":"Insulin resistance and type 2 diabetes in high-fat-fed mice are linked to high glycotoxin intake","volume":"54","author":"Sandu","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib157","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1530\/JOE-13-0175","article-title":"Dietary glycotoxins affect scavenger receptor expression and the hormonal profile of female rats","volume":"218","author":"Chatzigeorgiou","year":"2013","journal-title":"J Endocrinol"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib158","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2337\/dc13-0842","article-title":"Consumption of a diet low in advanced glycation end products for 4 weeks improves insulin sensitivity in overweight women","volume":"37","author":"Mark","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib159","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF03401321","article-title":"Impact of dietary modification of advanced glycation end products (AGEs) on the hormonal and metabolic profile of women with polycystic ovary syndrome (PCOS)","volume":"13","author":"Tantalaki","year":"2014","journal-title":"Hormones (Athens)"},{"key":"10.1016\/j.fertnstert.2016.08.031_bib160","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3132\/dvdr.2005.005","article-title":"RAGE polymorphisms and the heritability of insulin resistance: the Leeds family study","volume":"2","author":"Sullivan","year":"2005","journal-title":"Diab Vasc Dis Res"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028216627280?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028216627280?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T06:40:41Z","timestamp":1666507241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028216627280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":160,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0015028216627280"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2016.08.031","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polycystic ovary syndrome and environmental toxins","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2016.08.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a92016 American Society for Reproductive Medicine, Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}